Stay updated with breaking news from Brian Markison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
11.08.2022 - - Second quarter 2022 UPNEEQ net product sales of $8.4 million; 42% above first quarter - - Opportunity for cash runway to extend through 2023 following recently announced financings - - Expanded Board of Directors with the appointment of Alisa ...
-- Secured $68.9 million in committed financing through a combination of equity and non-dilutive debt financing -- -- Cash runway anticipated to extend...
-- Expects second quarter 2022 preliminary UPNEEQ net product sales of approximately $8.4 million, representing an increase of 42% from the first quarter 2022 -- -- Second quarter 2022 net product... | July 7, 2022
BRIDGEWATER, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company,...
12.05.2022 - First quarter 2022 UPNEEQ net product sales of $5.9 million; 90% growth over fourth quarter 2021 First quarter 2022 total revenues of $21.4 million, inclusive of $15.5 million from Santen License Agreement, with related cash receipt in April 2022 ...